With the advent of the digital age, the information that needs to be processed is rapidly increasing, and people are increasing the intensity of their eyes, so eye health problems need to be solved urgently. Under the background of continuous innovation of medical technology, the demand for diagnosis and treatment in the ophthalmic medical industry has grown rapidly, and the market space has been released. As a professional ophthalmic chain medical enterprise, Guangzheng Ophthalmology (002524) escorts people's eye health and wins the favor of the market.
The ophthalmic medical market is huge
Eye health is an important part of national health, including blindness, visual impairment seriously affects the people's physical health and quality of life, increases the burden on families and society, and is a major public health problem and social problem involving people's livelihood. In recent years, the number of outpatients with ophthalmic diseases in China has increased rapidly, the national eye health situation is extremely severe, and the demand for ophthalmic medical services is huge.
At present, the total number of myopia patients in China has reached 600 million, and the myopia population has a trend of high incidence and young age. At the same time, age-related eye diseases such as cataracts and diabetic retinopathy brought about by the aging of the population continue to grow. The growth rate of China's glaucoma market size is also on the rise. According to Frost & Sullivan statistics, the number of glaucoma patients in China increased from 18.1 million to 19.6 million from 2015 to 2019, and it is expected to grow to 23 million in 2030.
As the number of people with eye diseases gradually increases, the demand for treatment of eye diseases increases. At present, China's medical security system is constantly improving, people's income level is increasing, and the potential demand for ophthalmic medical care will continue to be transformed into a realistic and effective demand. Under the combined effect of increasing demand and consumption upgrading, the market capacity of ophthalmology diagnosis and treatment has been expanding.
As a regional ophthalmic chain medical institution, guangzheng ophthalmology has set up regional ophthalmology hospitals in many parts of the country that radiate local and surrounding areas with business scope after years of deep cultivation and development. The company has formed a strong core competitiveness in terms of technology, brand, scale, talent and scientific research, and has established a good reputation in the minds of the majority of patients with its high-quality service level.
At present, Guangzheng Ophthalmology has 12 non-public eye hospitals in operation, distributed in Shanghai, Jiangsu, Shandong, Jiangxi, Inner Mongolia, Henan, Chongqing, Sichuan and other places, providing ophthalmology-related professional diagnosis and treatment services to the majority of patients, including cataract diagnosis and treatment, glaucoma diagnosis and treatment, corneal disease diagnosis and treatment, lacrimal disease diagnosis and treatment, retinopathy diagnosis and treatment, other ocular surface disease diagnosis and treatment, medical optics, etc. After years of development, new horizon ophthalmology, a subsidiary of the company's ophthalmic medical business, enjoys a high reputation in China, and its technical level and business scale are in the leading position in the private ophthalmology industry.
Huge market demand, so that its performance to maintain a stable growth trend. According to the third quarterly report of Guangzheng Ophthalmology, the company achieved revenue of 779 million yuan in the first three quarters, an increase of 25.96% year-on-year; the net profit attributable to shareholders of listed companies was 45.9971 million yuan, an increase of 51.74% year-on-year, and the performance increased steadily. At present, the company has formed a leading advantage in some areas, and more and more hospitals have gradually occupied the largest local market share in terms of outpatient volume, surgical volume, operating income, etc., and have become a national ophthalmic chain institution in the leading position in the national private eye hospitals.
Integrated development of medical teaching and research platforms
Guangzheng Ophthalmology adheres to the integrated development of medical teaching and research platforms, and the influence of the industry has gradually increased. The company continues academic construction, successively hosts academic conferences such as the National Ophthalmology Pujiang Forum and the National Continuing Medical Education Tongji Fundus Disease Forum, adheres to the "Horizon Star National Ophthalmologist Talent Cultivation Program", and establishes the Guangzheng Ophthalmology Research Institute. At the same time, the company promotes the medical quality, academic level and operational efficiency of the institution to go hand in hand, continues to promote the policy of expert hospitalization, implements the two-level management mode of the hospital, strengthens the construction of sub-specialties, and improves the construction of institutional femtosecond cataract, high myopia specialty, floater disease, sugar mesh disease, etc., and the overall medical level of the institution has been significantly improved.
At the same time, Guangzheng Ophthalmology actively responds to the call of the state, promotes the sharing of high-quality medical resources, and provides more high-quality, convenient, efficient and safe eye health medical and health services for local residents. The company established the "Shanghai New Horizon Ophthalmology Center of Tongji Hospital Affiliated to Tongji University", and joined hands with the American Dashi Optical Equipment Company to build China's first "International EVO-ICL Quality Experience Center", which effectively enhanced the company's brand thickness.
Guangzheng Ophthalmology has long adhered to the talent introduction plan, built a platform for famous doctors, and gradually appeared the aggregation effect of outstanding talents in ophthalmology, and a group of domestic authoritative ophthalmology experts have joined New Horizon ophthalmology, constantly enriching the core expert team of the group and the talent strength of various hospitals. At the same time, the company has carried out practical training and training cooperation with universities in the region for a long time, continuously strengthened the efficient linkage between hospitals and universities, improved the talent training system, and continuously increased the talent reserve, providing sufficient talent guarantee for rapid development.
In addition, Guangzheng Ophthalmology continues to track and introduce the latest international ophthalmic diagnosis and treatment technology and advanced equipment, and uses various means such as remote consultation, graded referral, and expert teaching to improve the degree of sharing of technical resources and continuously improve clinical and scientific research technology capabilities. Based on this, the influence of Guangzheng Ophthalmology in the industry has been continuously improved, and the advantages of the medical teaching and research platform have been further reflected.
The layout of hospital chains has been accelerated and improved
Recently, Guangzheng Ophthalmology issued an announcement that Guangzheng New Vision, a wholly-owned subsidiary of the Company, intends to subscribe for a capital of RMB 10 million to invest in the establishment of Shanghai Guangzheng New Vision Pupil Eye Hospital Co., Ltd. according to the needs of strategic planning and business development, which is conducive to further deepening the company's industrial layout and meeting the needs of the company's business development. After the project is landed, it will add another big boost to the business performance of Guangzheng Ophthalmology.
After years of operation and development, Guangzheng Ophthalmology has formed a national chain operation model and enjoys a high reputation. On the basis of the development goal of "focusing on ophthalmic medical business, making the health industry bigger and stronger", the company further put forward the strategy of "priority layout of super first-tier cities" and the development goal of "research hospital", and will accelerate the investment and layout in the ophthalmic medical industry, continue to consolidate regional advantages, and strengthen radiation capabilities.
At present, the company's ophthalmic medical care focuses on large and medium-sized cities, giving priority to the layout of "north, Shanghai, Guangzhou, and Shenzhen" super-first-tier cities, radiating first-tier key cities, forming a chain diagnosis and treatment system with the "Yangtze River Delta", "Beijing-Tianjin-Hebei" and "Pearl River Delta" as the central platform, and continuously improving the breadth, depth and density of the medical network in the key layout area, taking the key cities as the center, intensive cultivation, and improving the construction from the urban hierarchical diagnosis and treatment network to the surrounding chain network system with one city and multiple hospitals and optometry clinics. Optimize resource allocation and facilitate patient visits.
Guangzheng Ophthalmology actively explores multi-level diversified medical services to meet people's diversified, differentiated and personalized ophthalmic medical service needs, and with the continuous improvement of the medical network, the company has achieved scale effect and chain advantages, and gradually grown into a national ophthalmic brand enterprise with regional advantages.